Roivant Sciences Ltd.
Symbol: ROIV
NASDAQ
11.25
USDMarket price today
2.0826
P/E Ratio
0.0316
PEG Ratio
9.07B
MRK Cap
- 0.00%
DIV Yield
Roivant Sciences Ltd. (ROIV) Financial Statements
Balance Sheet
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1692.1 | 2074 | 2055 | |||||
balance-sheet.row.short-term-investments | 0 | 15.3 | 13.6 | 0 | |||||
balance-sheet.row.net-receivables | 0 | 32.7 | 6.7 | 13.8 | |||||
balance-sheet.row.inventory | 0 | 2.8 | -16.5 | 63.9 | |||||
balance-sheet.row.other-current-assets | 0 | 121.8 | 82.2 | 54.3 | |||||
balance-sheet.row.total-current-assets | 0 | 1798.6 | 2146.5 | 2187 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 92.3 | 86.9 | 77 | |||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 144.9 | 0 | 0 | |||||
balance-sheet.row.long-term-investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.tax-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.other-non-current-assets | 0 | 49.5 | 25.8 | 36.1 | |||||
balance-sheet.row.total-non-current-assets | 0 | 591 | 438.6 | 402.7 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.account-payables | 0 | 37.8 | 34.6 | 20.6 | |||||
balance-sheet.row.short-term-debt | 0 | 52.4 | 11.4 | 12.3 | |||||
balance-sheet.row.tax-payables | 0 | 0.5 | 0.7 | 0.2 | |||||
balance-sheet.row.long-term-debt-total | 0 | 429 | 272.5 | 232.7 | |||||
Deferred Revenue Non Current | 0 | 0 | 13.7 | 0 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 15.1 | 128.2 | 180.2 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 509.6 | 339.3 | 308.7 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 22.5 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 65.2 | 73.9 | 74.7 | |||||
balance-sheet.row.total-liab | 0 | 782 | 546.2 | 527.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.retained-earnings | 0 | -3772.8 | -2763.7 | -1918.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -2.6 | -0.9 | 1.4 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | 5383 | 4803.6 | 3714.8 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 1607.6 | 2038.9 | 1797.8 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 2389.6 | 2585.1 | 2589.7 | |||||
balance-sheet.row.minority-interest | 0 | 449.8 | 404.5 | 264.2 | |||||
balance-sheet.row.total-equity | 0 | 2057.4 | 2443.4 | 2062 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 304.3 | 325.8 | 289.5 | |||||
balance-sheet.row.total-debt | 0 | 481.4 | 283.9 | 245 | |||||
balance-sheet.row.net-debt | 0 | -1195.4 | -1776.5 | -1810.1 |
Cash Flow Statement
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | -1115.5 | -924.1 | -900.2 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 18.9 | 5.9 | 0 | |||||
cash-flows.row.deferred-income-tax | 0 | -4.4 | -5.9 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 217.8 | 565 | 85 | |||||
cash-flows.row.change-in-working-capital | 0 | 6.3 | 15.7 | 71.9 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 4.4 | 15.4 | 3.8 | |||||
cash-flows.row.other-working-capital | 0 | 2 | 0.3 | 68.2 | |||||
cash-flows.row.other-non-cash-items | 0 | 33.4 | -334.3 | 191.2 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.acquisitions-net | 0 | 107.9 | 0 | 0 | |||||
cash-flows.row.purchases-of-investments | 0 | 0 | 0 | -28.3 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 0 | 320.2 | 0 | |||||
cash-flows.row.other-investing-activites | 0 | -139.4 | 0.6 | 2.4 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -44.3 | 303.3 | -31.7 | |||||
cash-flows.row.debt-repayment | 0 | -30.1 | -21.6 | 0 | |||||
cash-flows.row.common-stock-issued | 0 | 379.7 | 313.4 | 455.8 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0.3 | 0 | -0.1 | |||||
cash-flows.row.dividends-paid | 0 | -162.7 | 0 | 0 | |||||
cash-flows.row.other-financing-activites | 0 | 312.3 | 15 | 0.6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 499.5 | 306.8 | 456.3 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 6.3 | 0 | 0 | |||||
cash-flows.row.net-change-in-cash | 0 | -381.9 | -67.6 | -127.6 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 1692.1 | 2074 | 2141.7 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 2074 | 2141.7 | 2269.3 | |||||
cash-flows.row.operating-cash-flow | 0 | -843.4 | -677.7 | -552.1 | |||||
cash-flows.row.capital-expenditure | 0 | -12.7 | -17.4 | -5.8 | |||||
cash-flows.row.free-cash-flow | 0 | -856.1 | -695.2 | -557.9 |
Income Statement Row
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 61.3 | 55.3 | 23.8 | |||||
income-statement-row.row.cost-of-revenue | 0 | 13.1 | 9 | 2.1 | |||||
income-statement-row.row.gross-profit | 0 | 48.2 | 46.3 | 21.7 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.operating-expenses | 0 | 1125.7 | 1258.1 | 496.5 | |||||
income-statement-row.row.cost-and-expenses | 0 | 1138.8 | 1267 | 498.6 | |||||
income-statement-row.row.interest-income | 0 | 32.2 | 0.4 | 1.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -62.2 | -0.1 | -33.4 | |||||
income-statement-row.row.total-operating-expenses | 0 | -147.3 | 288 | 172.4 | |||||
income-statement-row.row.interest-expense | 0 | 28 | 7 | 2.8 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | -30 | -288.1 | 560.4 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | -1077.6 | -1211.7 | -1070.9 | |||||
income-statement-row.row.income-before-tax | 0 | -1224.8 | -923.7 | -898.5 | |||||
income-statement-row.row.income-tax-expense | 0 | 5.2 | 0.4 | 1.7 | |||||
income-statement-row.row.net-income | 0 | -1230 | -924.1 | -900.2 |
Frequently Asked Question
What is Roivant Sciences Ltd. (ROIV) total assets?
Roivant Sciences Ltd. (ROIV) total assets is 2389604000.000.
What is enterprise annual revenue?
The annual revenue is N/A.
What is firm profit margin?
Firm profit margin is 0.876.
What is company free cash flow?
The free cash flow is -1.047.
What is enterprise net profit margin?
The net profit margin is 35.091.
What is firm total revenue?
The total revenue is 39.165.
What is Roivant Sciences Ltd. (ROIV) net profit (net income)?
The net profit (net income) is -1230024000.000.
What is firm total debt?
The total debt is 481404000.000.
What is operating expences number?
The operating expences are 1125721000.000.
What is company cash figure?
Enretprise cash is 0.000.